Philip Comp to Humans
This is a "connection" page, showing publications Philip Comp has written about Humans.
Connection Strength
0.394
-
Phosphofructokinase deficiency and portal and mesenteric vein thrombosis. Am J Med Sci. 2011 May; 341(5):417-9.
Score: 0.022
-
Abnormal melt curve profile during prothrombin 20210G --> A analysis due to the 20209C --> T variant. Blood Coagul Fibrinolysis. 2006 Oct; 17(7):599-602.
Score: 0.016
-
Should coagulation tests be used to determine which oral contraceptive users have an increased risk of thrombophlebitis? Contraception. 2006 Jan; 73(1):4-5.
Score: 0.015
-
Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery. Pharmacotherapy. 2003 Jun; 23(6):772-87.
Score: 0.012
-
Treatment and management of acute venous thromboembolic disease. Thromb Res. 2003; 111(1-2):3-8.
Score: 0.012
-
Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med. 2002 Nov; 126(11):1337-48.
Score: 0.012
-
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am. 2001 Mar; 83(3):336-45.
Score: 0.011
-
An association between plasma free protein s concentration and risk of coronary heart disease in middle-aged men. Thromb Res. 2001 Jan 15; 101(2):1-11.
Score: 0.011
-
Advances in the etiology and treatment of venous thromboembolism. Adv Intern Med. 1999; 44:59-89.
Score: 0.009
-
A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group. Orthopedics. 1998 Oct; 21(10):1123-8.
Score: 0.009
-
Activated factor VII levels in patients with angiographically confirmed coronary artery disease. Am J Cardiol. 1997 Jul 15; 80(2):217-9.
Score: 0.008
-
Progression of an untreated pseudotumor. Haemophilia. 2017 09; 23(5):e464-e466.
Score: 0.008
-
Thrombophilic mechanisms of OCs. Int J Fertil Womens Med. 1997; Suppl 1:170-6.
Score: 0.008
-
Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study Group. Am J Cardiol. 1996 Nov 01; 78(9):1074-6.
Score: 0.008
-
Fibrinogen levels in women having coronary angiography. Am J Cardiol. 1996 Jul 01; 78(1):15-8.
Score: 0.008
-
Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis. Thromb Res. 2015 Dec; 136(6):1120-5.
Score: 0.007
-
Effect of treatment with low-dose warfarin-aspirin on activated factor VII. Blood. 1995 Jun 01; 85(11):3034-9.
Score: 0.007
-
Preliminary data from a field trial of the PFA-100 system. Semin Thromb Hemost. 1995; 21 Suppl 2:113-21.
Score: 0.007
-
Preventing systemic embolism in patients with abnormal ventricular function. Cardiol Clin. 1994 Aug; 12(3):477-85.
Score: 0.007
-
Contraceptive choices in women with coagulation disorders. Am J Obstet Gynecol. 1993 Jun; 168(6 Pt 2):1990-3.
Score: 0.006
-
Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993 Feb 01; 81(3):734-44.
Score: 0.006
-
Coumarin-induced skin necrosis. Incidence, mechanisms, management and avoidance. Drug Saf. 1993 Feb; 8(2):128-35.
Score: 0.006
-
Recent advances in understanding clotting and evaluating patients with recurrent thrombosis. Am J Obstet Gynecol. 1992 Oct; 167(4 Pt 2):1184-91.
Score: 0.006
-
Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. Thromb Res. 2012 Sep; 130(3):381-9.
Score: 0.006
-
Free protein S levels are elevated in familial C4b-binding protein deficiency. Blood. 1990 Dec 15; 76(12):2527-9.
Score: 0.005
-
Warfarin-induced skin necrosis. Semin Thromb Hemost. 1990 Oct; 16(4):293-8.
Score: 0.005
-
In vitro studies with the platelet-reactive antibody 50H.19 and its fragments. Thromb Res. 1990 Jun 01; 58(5):493-504.
Score: 0.005
-
Laboratory evaluation of protein S status. Semin Thromb Hemost. 1990 Apr; 16(2):177-81.
Score: 0.005
-
Overview of the hypercoagulable states. Semin Thromb Hemost. 1990 Apr; 16(2):158-61.
Score: 0.005
-
Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest. 1988 May; 81(5):1445-54.
Score: 0.004
-
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009 Jan; 24(1):1-9.
Score: 0.004
-
Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis. Arteriosclerosis. 1987 Sep-Oct; 7(5):456-62.
Score: 0.004
-
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007 Sep; 5(9):1854-61.
Score: 0.004
-
Oral contraceptives and gender affect protein S status. Blood. 1987 Feb; 69(2):692-4.
Score: 0.004
-
The relationship between arterial elasticity and metabolic syndrome features. Angiology. 2007 Feb-Mar; 58(1):5-10.
Score: 0.004
-
Analysis of protein C and protein S in disease states. Dev Biol Stand. 1987; 67:75-82.
Score: 0.004
-
Anticoagulation proteins C and S. Adv Exp Med Biol. 1987; 214:47-54.
Score: 0.004
-
Clinical implications of the protein C/protein S system. Ann N Y Acad Sci. 1987; 509:149-55.
Score: 0.004
-
Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986 Oct; 68(4):881-5.
Score: 0.004
-
Traces of factor VIIa modulate thromboplastin sensitivity to factors V, VII, X, and prothrombin. J Thromb Haemost. 2006 Jul; 4(7):1553-8.
Score: 0.004
-
The regulation of hemostasis: the protein C system. N Engl J Med. 1986 May 15; 314(20):1298-304.
Score: 0.004
-
An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood. 1986 Feb; 67(2):504-8.
Score: 0.004
-
Hereditary disorders predisposing to thrombosis. Prog Hemost Thromb. 1986; 8:71-102.
Score: 0.004
-
Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am. 2005 Oct; 87(10):2169-77.
Score: 0.004
-
Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost. 2005 May; 3(5):962-8.
Score: 0.004
-
Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. Int Immunol. 2005 May; 17(5):501-11.
Score: 0.004
-
Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med. 1984 Dec 13; 311(24):1525-8.
Score: 0.003
-
Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest. 1984 Dec; 74(6):2082-8.
Score: 0.003
-
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care. 2004 Apr; 8(2):R82-90.
Score: 0.003
-
Heparin-protein C interaction. Nouv Rev Fr Hematol. 1984; 26(4):239-42.
Score: 0.003
-
The activation and effects of protein C, an antithrombotic protein, in vivo. Surv Synth Pathol Res. 1984; 3(1):31-7.
Score: 0.003
-
Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood. 1984 Jan; 63(1):15-21.
Score: 0.003
-
New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic Biol Med. 2004 Jan 01; 36(1):1-15.
Score: 0.003
-
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med. 2003 Oct 30; 349(18):1703-12.
Score: 0.003
-
Bimodal distribution of soluble endothelial protein C receptor levels in healthy populations. J Thromb Haemost. 2003 Apr; 1(4):855-6.
Score: 0.003
-
B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood. 2003 Jan 15; 101(2):576-84.
Score: 0.003
-
Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study. Vasc Endovascular Surg. 2002 Mar-Apr; 36(2):83-91.
Score: 0.003
-
Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc Natl Acad Sci U S A. 2001 Dec 18; 98(26):15131-6.
Score: 0.003
-
Relatively normal human lymphopoiesis but rapid turnover of newly formed B cells in transplanted nonobese diabetic/SCID mice. J Immunol. 2001 Sep 15; 167(6):3033-42.
Score: 0.003
-
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation. 2001 Jul 03; 104(1):74-8.
Score: 0.003
-
Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility. Arch Intern Med. 2000 Feb 14; 160(3):309-13.
Score: 0.002
-
Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis. J Rheumatol. 2000 Feb; 27(2):384-90.
Score: 0.002
-
Coagulolysis assay in the detection of deep vein thrombosis in the orthopedic patient. A preliminary report. Clin Orthop Relat Res. 1979 Jul-Aug; (142):190-5.
Score: 0.002
-
Hyperhomocysteinemia, aortic thrombus, and peripheral arterial emboli--a case report. Angiology. 1999 Jul; 50(7):599-603.
Score: 0.002
-
A rapid purification of streptokinase by affinity chromatography. Thromb Res. 1979 Feb-Mar; 14(2-3):405-11.
Score: 0.002
-
The dilute whole blood clot lysis assay: a screening method for identifying postoperative patients with a high incidence of deep venous thrombosis. J Lab Clin Med. 1979 Jan; 93(1):120-7.
Score: 0.002
-
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med. 1998 Jan 01; 128(1):1-7.
Score: 0.002
-
PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost. 1998; 24(2):195-202.
Score: 0.002
-
Cytokine-induced alteration of platelet and hemostatic function. Stem Cells. 1996; 14 Suppl 1:154-62.
Score: 0.002
-
Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy. Atherosclerosis. 1995 Apr 24; 114(2):203-11.
Score: 0.002
-
On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest. 1995 Jan; 95(1):309-16.
Score: 0.002
-
Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group. Am J Cardiol. 1994 Oct 01; 74(7):657-61.
Score: 0.002
-
Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal. Am J Cardiol. 1993 Apr 01; 71(10):816-22.
Score: 0.002
-
Afibrinogenemia and hypobetalipoproteinemia in a kindred. Arch Intern Med. 1991 Apr; 151(4):800-4.
Score: 0.001
-
A 5.3-kb deletion including exon XIII of the protein S alpha gene occurs in two protein S-deficient families. Blood. 1991 Feb 01; 77(3):551-9.
Score: 0.001
-
Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. J Clin Invest. 1986 Feb; 77(2):416-25.
Score: 0.001
-
Biochemical and physiological aspects of protein c. Ric Clin Lab. 1984 Jul-Sep; 14(3):455-68.
Score: 0.001